Christian Brander Selected Research

Christian Brander Research Topics

Disease

52	Infections 09/2023 - 02/2002
31	HIV Infections (HIV Infection) 01/2023 - 12/2002
19	Viremia 09/2023 - 03/2004
12	Disease Progression 01/2018 - 12/2004
8	Virus Diseases (Viral Diseases) 01/2020 - 12/2002
4	Neoplasms (Cancer) 09/2023 - 06/2004
4	Inflammation (Inflammations) 12/2022 - 12/2004
4	Acquired Immunodeficiency Syndrome (AIDS) 05/2020 - 11/2007
4	Human Influenza (Influenza) 06/2013 - 04/2004
3	COVID-19 11/2022 - 08/2020
3	Vaccinia 01/2015 - 09/2006
3	Persistent Infection 06/2012 - 09/2006
2	Communicable Diseases (Infectious Diseases) 11/2020 - 01/2019
2	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2017 - 02/2013
2	Hypersensitivity (Allergy) 06/2013 - 12/2012
2	Chronic Hepatitis B 02/2013 - 01/2013
2	Kaposi Sarcoma (Kaposi's Sarcoma) 09/2009 - 06/2007
2	Epstein-Barr Virus Infections 11/2005 - 12/2002
1	Body Weight (Weight, Body) 12/2021
1	Disease Susceptibility (Diathesis) 11/2021
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2020
1	Tuberculosis (Tuberculoses) 08/2019
1	Meningitis 08/2019
1	Miliary Tuberculosis 08/2019
1	Atrophy 01/2019
1	Chronic Hepatitis C 06/2014

Drug/Important Bio-Agent (IBA)

36	EpitopesIBA 11/2022 - 02/2002
28	VaccinesIBA 09/2023 - 02/2002
15	HLA-B Antigens (HLA-B)IBA 11/2021 - 12/2004
11	Proteins (Proteins, Gene)FDA Link 05/2019 - 02/2002
7	AntigensIBA 12/2022 - 12/2002
7	Peptides (Polypeptides)IBA 08/2020 - 04/2004
6	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021 - 11/2005
6	Antiviral Agents (Antivirals)IBA 01/2018 - 06/2007
6	HLA-B57 antigenIBA 01/2018 - 08/2005
5	RNA (Ribonucleic Acid)IBA 01/2017 - 08/2005
5	LigandsIBA 11/2014 - 06/2007
5	AIDS VaccinesIBA 06/2013 - 08/2004
5	Interferon-gamma (Interferon, gamma)IBA 09/2009 - 04/2004
4	Biomarkers (Surrogate Marker)IBA 09/2023 - 01/2008
4	ProteomeIBA 09/2023 - 01/2008
4	romidepsin (FK228)FDA Link 09/2023 - 01/2020
3	CytokinesIBA 12/2022 - 03/2015
3	HLA-A Antigens (HLA-A)IBA 11/2021 - 12/2004
3	Viral AntigensIBA 02/2013 - 06/2004
2	Immunoglobulin G (IgG)IBA 11/2022 - 01/2022
2	Neutralizing AntibodiesIBA 01/2022 - 02/2013
2	Viral ProteinsIBA 01/2020 - 06/2012
2	Messenger RNA (mRNA)IBA 11/2018 - 08/2007
2	Amino Acids FDA Link 01/2018 - 04/2004
2	Immunoglobulins (Immunoglobulin)IBA 01/2017 - 04/2008
2	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2017 - 10/2005
2	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 04/2008
2	KIR ReceptorsIBA 03/2015 - 11/2007
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2013 - 03/2009
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2012 - 03/2008
2	Human Immunodeficiency Virus ProteinsIBA 04/2009 - 01/2007
2	ChemokinesIBA 08/2007 - 12/2004
2	Chemokine ReceptorsIBA 08/2007 - 12/2004
2	Immunodominant EpitopesIBA 04/2005 - 12/2002
1	Tumor Necrosis Factor Ligand Superfamily Member 14IBA 01/2023
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2023
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2023
1	NAD (NADH)IBA 01/2023
1	SynucleinsIBA 01/2023
1	Sirtuin 2IBA 01/2023
1	AntibodiesIBA 12/2022
1	Broadly Neutralizing AntibodiesIBA 12/2022
1	mRNA VaccinesIBA 11/2022
1	GuanineIBA 01/2021
1	CytosineIBA 01/2021
1	Interleukin-15 (Interleukin 15)IBA 01/2021
1	CC ChemokinesIBA 01/2021
1	Histone Deacetylase InhibitorsIBA 01/2020
1	Complement System Proteins (Complement)IBA 06/2019
1	Oxygen (Dioxygen)IBA 01/2019
1	Sulfates (Sulfates, Inorganic)IBA 01/2019
1	NitrogenIBA 01/2019
1	ZincIBA 01/2019
1	MucinsIBA 01/2017
1	AcidsIBA 01/2017
1	Granzymes (Granzyme)IBA 02/2016
1	Interleukin-22 (IL-22)IBA 03/2015
1	Interleukin-10 (Interleukin 10)IBA 03/2015
1	Interleukin-13IBA 03/2015
1	HLA-C Antigens (HLA-C)IBA 03/2015
1	Disulfiram (Antabuse)FDA Link 01/2015
1	PolyproteinsIBA 01/2015
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 08/2014
1	HLA-B*07 antigenIBA 05/2014
1	influenza matrix peptide (58-66)IBA 06/2013
1	human immunodeficiency virus p17 gag peptideIBA 06/2013

Therapy/Procedure

7	Therapeutics 08/2019 - 03/2007
5	Highly Active Antiretroviral Therapy (HAART) 01/2020 - 06/2007
3	Art Therapy 01/2022 - 01/2019
3	Liver Transplantation 06/2014 - 04/2008
2	Withholding Treatment 01/2020 - 01/2017
2	Drug Therapy (Chemotherapy) 09/2009 - 06/2007
1	Aftercare (After-Treatment) 01/2017
1	Immunotherapy 11/2014